Opexa has developed significant expertise in cellular therapy manufacturing since its formation and has successfully manufactured over 1000 personalized doses of Tcelna. All manufacturing is conducted at Opexa's cGMP facility using its proprietary T-cell technology in The Woodlands, Texas.
Opexa has demonstrated its ability to successfully procure, process, and distribute Tcelna safely and securely to geographically dispersed patients without difficulty or infringement of any regulation. Opexa's 10,200 sq. ft. operation and cGMP facility located in The Woodlands, Texas provides space for all research and development, quality systems, and manufacturing capacity to support clinical trials with three ISO7 cGMP (current Good Manufacturing Practice) manufacturing suites and a specialized Flow Cytometry laboratory.